I was thinking the same since this news came out. I wondered whether YF was fully aware of its capabilities and if IMU were also, and how much competition it might be, if there was a risk of other bio techs paying big bucks for a licence for it, and if anything was being discussed or assessed etc behind the scenes. IMU is achieving some remarkable R&D, so IMO, making the most out of everything known can strengthen and further de-risk IMU’s goals for the next 12 months.
I was thinking the same since this news came out. I wondered...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.002(4.17%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.6¢ | $400.2K | 8.603M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1876197 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 613421 | 6 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |